Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. EYPT
EYPT logo

EYPT

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

EYPT News

EyePoint to Participate in Upcoming Healthcare Conferences

May 19 2026Newsfilter

EyePoint Grants Stock Options to New Employees as Inducement Awards

May 18 2026Newsfilter

EyePoint (EYPT) Q1 2026 Earnings Transcript

May 07 2026NASDAQ.COM

EyePoint Pharmaceuticals Q1 2026 Earnings Call Insights

May 06 2026seekingalpha

EyePoint Pharmaceuticals to Announce Q1 Earnings on May 6

May 05 2026seekingalpha

Arvinas Shares Surge 6.9% on Positive Pipeline Expectations

Apr 02 2026NASDAQ.COM

EyePoint Sues Ocular for False Claims on Duravyu

Mar 21 2026seekingalpha

EYEPOINT INC - SEC Filing Claims Ocular Therapeutix Made False Statements About EYEPOINT and DURAVYU

Mar 20 2026moomoo

Parkman Healthcare Partners Acquires New Stake in EyePoint Pharmaceuticals

Mar 16 2026Fool

Parkman Acquires New Stake in EyePoint

Mar 16 2026NASDAQ.COM

Wall Street Analysts Adjust Ratings

Mar 05 2026Benzinga

EyePoint, Inc. Q4 2025 Earnings Call Insights

Mar 04 2026seekingalpha

EyePoint Pharmaceuticals Q4 Earnings Miss Expectations

Mar 04 2026seekingalpha

EyePoint Pharmaceuticals to Announce Q4 Earnings on March 4

Mar 03 2026seekingalpha

iShares Expanded Tech-Software ETF Underperforms

Feb 23 2026NASDAQ.COM

EYPT Options Trading Analysis and Strategies

Feb 03 2026NASDAQ.COM